Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study

There are concerns that hypertension control may decrease during the COVID-19 pandemic. This study evaluated the impact of the COVID-19 pandemic on office blood pressure (OBP) and home blood pressure monitoring (HBPM) control in a large Brazilian nationwide sample. The results of an adjusted spline...

Full description

Saved in:
Bibliographic Details
Published in:Hypertension research 2022-02, Vol.45 (2), p.364-368
Main Authors: Feitosa, Fabiana G A M, Feitosa, Audes D M, Paiva, Annelise M G, Mota-Gomes, Marco A, Barroso, Weimar S, Miranda, Roberto D, Barbosa, Eduardo C D, Brandão, Andréa A, Lima-Filho, José L, Sposito, Andrei C, Coca, Antonio, Nadruz, Jr, Wilson
Format: Article
Language:English
Subjects:
Blood Pressure
Blood Pressure Monitoring, Ambulatory
Brief Communication
Coronaviruses
COVID-19
Humans
Hypertension
Hypertension - diagnosis
Hypertension - drug therapy
Hypertension - epidemiology
Pandemics
SARS-CoV-2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There are concerns that hypertension control may decrease during the COVID-19 pandemic. This study evaluated the impact of the COVID-19 pandemic on office blood pressure (OBP) and home blood pressure monitoring (HBPM) control in a large Brazilian nationwide sample. The results of an adjusted spline analysis evaluating the trajectory of OBP and HBPM control from 01/Jan/2019 to 31/Dec/2020 among independent participants who were untreated (n = 24,227) or treated (n = 27,699) with antihypertensive medications showed a modest and transient improvement in OBP control among treated individuals, which was restricted to the early months following the COVID-19 pandemic outbreak. Furthermore, slight reductions in OBP and HBPM values were detected in the early months following the COVID-19 pandemic outbreak among treated (n = 987) participants for whom blood pressure measurements before and during the pandemic were available, but not among untreated (n = 495) participants. In conclusion, we found no major adverse influence of the COVID-19 pandemic on OBP and HBPM control in a large nationwide sample.
ISSN:0916-9636
1348-4214
DOI:10.1038/s41440-021-00784-1